Ellis Andrea
SEC CIK 1877680 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Dir | 39.7K | $100.7K | $7.87M | 13 | 2022-03-15 | 2026-07-09 |
Most active insiders at BBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kumar Neil | CEO, Dir | — | $61.54M |
| 2 | Cook Jennifer E. | Dir | — | $21.92M |
| 3 | MCCORMICK FRANK | Dir | — | $13.31M |
| 4 | Lo Andrew | Dir | — | $6.32M |
| 5 | Ellis Andrea | Dir | — | $5.65M |
| 6 | Valantine Hannah | Dir | — | $4.37M |
| 7 | DANIELS RONALD J | Dir | — | $3.89M |
| 8 | Trimarchi Thomas | Pres, CFO | — | $3.03M |
| 9 | Scott Randal W. | Dir | — | $2.09M |
| 10 | Apuli Maricel | CAO | — | $621.7K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-13 16:41 | 2026-07-09 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | M - OptEx | $16.75 | +17.2K | 39.7K | +76% | +$287.5K |
| DT | 2026-07-13 16:41 | 2026-07-09 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | S - Sale+OE | $84.00 | -17.2K | 22.6K | -43% | -$1.44M |
| D | 2026-06-24 18:05 | 2026-06-22 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | A - Grant | $0.00 | +3,990 | 22.6K | +21% | $0 |
| D | 2026-03-06 | 2026-03-04 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | M - OptEx | $8.45 | +64.9K | 83.5K | +349% | +$548.6K |
| D | 2026-03-06 | 2026-03-04 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | S - Sale+OE | $64.87 | -64.9K | 18.6K | -78% | -$4.21M |
| DT | 2025-08-07 | 2025-08-05 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | M - OptEx | $16.75 | +17.2K | 35.8K | +92% | +$287.5K |
| DT | 2025-08-07 | 2025-08-05 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | S - Sale+OE | $49.00 | -17.2K | 18.6K | -48% | -$841.2K |
| D | 2025-06-24 | 2025-06-20 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | A - Grant | $0.00 | +6,589 | 18.6K | +55% | $0 |
| DT | 2025-04-16 | 2025-04-14 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | M - OptEx | $8.45 | +10.0K | 22.0K | +83% | +$84.5K |
| DT | 2025-04-16 | 2025-04-14 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | S - Sale+OE | $35.00 | -10.0K | 12.0K | -45% | -$350.0K |
| DT | 2025-04-03 | 2025-04-01 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | S - Sale+OE | $34.05 | -30.0K | 12.0K | -71% | -$1.02M |
| DT | 2025-04-03 | 2025-04-01 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | M - OptEx | $8.45 | +30.0K | 42.0K | +250% | +$253.5K |
| 2022-03-17 | 2022-03-15 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Dir | P - Purchase | $8.39 | +12.0K | 12.0K | New | +$100.7K |
Purchase Sale Sale after option exercise All abbreviations